2 Matching Annotations
  1. Jul 2018
    1. On 2015 Jun 28, Erick H Turner commented:

      Below are DOIs and links to FDA review documents for the 8 older antidepressant drugs whose reviews are not available on the FDA website Drugs@FDA.

      doi:10.6083/M4542M8J Bupropion SR http://digitalcommons.ohsu.edu/fdadrug/21

      doi:10.6083/M41C1VJT Fluoxetine http://digitalcommons.ohsu.edu/fdadrug/22

      doi:10.6083/M48W3C0Z Mirtazapine http://digitalcommons.ohsu.edu/fdadrug/20

      doi:10.6083/M4WM1C2X Nefazodone http://digitalcommons.ohsu.edu/fdadrug/23

      doi:10.6083/M4HD7TC4 Paroxetine http://digitalcommons.ohsu.edu/fdadrug/26

      doi:10.6083/M4CN72MB Sertraline http://digitalcommons.ohsu.edu/fdadrug/27

      doi:10.6083/M4RV0MCN Venlafaxine http://digitalcommons.ohsu.edu/fdadrug/24

      doi:10.6083/M4N58K2D Venlafaxine XR http://digitalcommons.ohsu.edu/fdadrug/25

      Because they were not acquired directly from the FDA but rather indirectly through colleagues who had obtained them via FOIA requests, the order of the 'hard copy' pages may have been shuffled in some cases. For a 'cleaner' copy, one might need to place a new FOIA request with the FDA (http://www.accessdata.fda.gov/scripts/foi/FOIRequest/requestinfo.cfm).

      As for the 4 newer antidepressant drugs, as stated in the article, those reviews are downloadable from Drugs@FDA. If assistance is needed in navigating to and through that site, the "cookbook" article of mine available at http://www.bmj.com/content/347/bmj.f5992 may be useful.


      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.

  2. Feb 2018
    1. On 2015 Jun 28, Erick H Turner commented:

      Below are DOIs and links to FDA review documents for the 8 older antidepressant drugs whose reviews are not available on the FDA website Drugs@FDA.

      doi:10.6083/M4542M8J Bupropion SR http://digitalcommons.ohsu.edu/fdadrug/21

      doi:10.6083/M41C1VJT Fluoxetine http://digitalcommons.ohsu.edu/fdadrug/22

      doi:10.6083/M48W3C0Z Mirtazapine http://digitalcommons.ohsu.edu/fdadrug/20

      doi:10.6083/M4WM1C2X Nefazodone http://digitalcommons.ohsu.edu/fdadrug/23

      doi:10.6083/M4HD7TC4 Paroxetine http://digitalcommons.ohsu.edu/fdadrug/26

      doi:10.6083/M4CN72MB Sertraline http://digitalcommons.ohsu.edu/fdadrug/27

      doi:10.6083/M4RV0MCN Venlafaxine http://digitalcommons.ohsu.edu/fdadrug/24

      doi:10.6083/M4N58K2D Venlafaxine XR http://digitalcommons.ohsu.edu/fdadrug/25

      Because they were not acquired directly from the FDA but rather indirectly through colleagues who had obtained them via FOIA requests, the order of the 'hard copy' pages may have been shuffled in some cases. For a 'cleaner' copy, one might need to place a new FOIA request with the FDA (http://www.accessdata.fda.gov/scripts/foi/FOIRequest/requestinfo.cfm).

      As for the 4 newer antidepressant drugs, as stated in the article, those reviews are downloadable from Drugs@FDA. If assistance is needed in navigating to and through that site, the "cookbook" article of mine available at http://www.bmj.com/content/347/bmj.f5992 may be useful.


      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.